We are live on ! Find out more
ZIVOW

Zivo Bioscience, Inc. Warrants
ZIVOW

Delisted

ZIVOW was delisted on the 24th of November, 2023.

Back to rankings

5 hedge funds and large institutions have $89K invested in Zivo Bioscience, Inc. Warrants in 2021 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

31% more capital invested

Capital invested by funds: $68K → $89K (+$21K)

25% more funds holding

Funds holding: 4 → 5 (+1)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
5
Holders Change
+1
Holders Change %
+25%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$121

Top Sellers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
-$19.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Ayrton Capital
Connecticut
$46K +$45.4K +48,850 New
WAM
2
Warberg Asset Management
Illinois
$18K -$19.1K -20,559 -51%
CH
3
CVI Holdings
Delaware
$15K – – –
VCA
4
Verdence Capital Advisors
Maryland
$9K – – –
UBS Group
5
UBS Group
Switzerland
$1K +$121 +130 +10%

ZIVOW Hedge Fund Activity: Q4 2021 in Review

5 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Zivo Bioscience, Inc. Warrants (ZIVOW) for Q4 2021, worth a combined $89K — up 31% from $68K a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ZIVOW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 1 trimmed.

The largest buyer was UBS Group, adding an estimated $121. The largest seller was Warberg Asset Management, cutting an estimated $19.1K.

  • 5 institutional investors held Zivo Bioscience, Inc. Warrants (ZIVOW) as of Q4 2021, up from 4 in Q3 2021.
  • Funds reported $89K of Zivo Bioscience, Inc. Warrants stock for Q4 2021, up 31% quarter-over-quarter.
  • 1 fund opened new Zivo Bioscience, Inc. Warrants positions in Q4 2021 and 0 closed out, a net change of +1 holder.
  • The largest Zivo Bioscience, Inc. Warrants buyer in Q4 2021 was UBS Group, an estimated $121 added.
  • The largest Zivo Bioscience, Inc. Warrants seller in Q4 2021 was Warberg Asset Management, an estimated $19.1K sold.

Based on aggregated 13F filings for Q4 2021.